Cargando…

Effectiveness of Yushen Hezhi therapy for postmenopausal osteoporosis: An overview of systematic reviews of randomized controlled trials

OBJECTIVE: To review systematic reviews (SRs) and meta-analyses (MAs) of Yushen Hezhi therapy (YSHZT) for postmenopausal osteoporosis (PMOP) to provide an evidence-based recommendation for researchers and decision makers. METHODS: We searched the PubMed, Cochrane Library, Embase, China National Know...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhao, Jinlong, Xiao, Xiao, Zhou, Guanghui, Xu, Nanjun, Liu, Jun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Endocrinology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9548895/ https://www.ncbi.nlm.nih.gov/pubmed/36225202 http://dx.doi.org/10.3389/fendo.2022.1015483

Ejemplares similares

Exploration of the Molecular Mechanism of Polygonati Rhizoma in the Treatment of Osteoporosis Based on Network Pharmacology and Molecular Docking
por: Zhao, Jinlong, et al.
Publicado: (2022)

Does the VDR gene polymorphism influence the efficacy of denosumab therapy in postmenopausal osteoporosis?
por: Wawrzyniak, Anna, et al.
Publicado: (2023)

Efficacy of Yushen Tongluo Granule Combined with Clomiphene Citrate for Anovulatory Infertility: A Double-Blind, Randomized, Placebo-Controlled Clinical Trial
por: Xu, Huayun, et al.
Publicado: (2022)

Identification of ferroptosis-associated biomarkers for the potential diagnosis and treatment of postmenopausal osteoporosis
por: Hu, Yunxiang, et al.
Publicado: (2022)

Comparative Efficacy of Xianling Gubao Capsules in Improving Bone Mineral Density in Postmenopausal Osteoporosis: A Network Meta-Analysis
por: Luo, Ming-hui, et al.
Publicado: (2022)

Analysis and Validation of Hub Genes in Blood Monocytes of Postmenopausal Osteoporosis Patients
por: Deng, Yi-Xuan, et al.
Publicado: (2022)

MicroRNAs in Serum Exosomes as Circulating Biomarkers for Postmenopausal Osteoporosis
por: Shi, Hongli, et al.
Publicado: (2022)

Discovery of Potential Biomarkers for Postmenopausal Osteoporosis Based on Untargeted GC/LC-MS
por: Kou, Jun, et al.
Publicado: (2022)

Multiple doses of SHR-1222, a sclerostin monoclonal antibody, in postmenopausal women with osteoporosis: A randomized, double-blind, placebo-controlled, dose-escalation phase 1 trial
por: Dai, Zhijie, et al.
Publicado: (2023)

Disturbed bone marrow adiposity in patients with Cushing’s syndrome and glucocorticoid- and postmenopausal- induced osteoporosis
por: Sørensen, Nina N., et al.
Publicado: (2023)

Association of Vitamin D Receptor Gene Variation With Osteoporosis Risk in Belarusian and Lithuanian Postmenopausal Women
por: Marozik, Pavel M., et al.
Publicado: (2018)

Bone Microarchitecture in Obese Postmenopausal Chinese Women: The Chinese Vertebral Osteoporosis Study (ChiVOS)
por: Qi, Wenting, et al.
Publicado: (2022)

Roles of Altered Macrophages and Cytokines: Implications for Pathological Mechanisms of Postmenopausal Osteoporosis, Rheumatoid Arthritis, and Alzheimer’s Disease
por: Xu, Yunteng, et al.
Publicado: (2022)

Complement receptor C5aR1 on osteoblasts regulates osteoclastogenesis in experimental postmenopausal osteoporosis
por: Bülow, Jasmin Maria, et al.
Publicado: (2022)

Profile of Abaloparatide and Its Potential in the Treatment of Postmenopausal Osteoporosis
por: Tella, Sri Harsha, et al.
Publicado: (2017)

Impact of Osteoporosis in Postmenopausal Women With Primary Knee Osteoarthritis
por: Zamzam, Mohammed, et al.
Publicado: (2023)

Vitamin D Supplementation Improves Handgrip Strength in Postmenopausal Women: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
por: Zhang, Jia-Li, et al.
Publicado: (2022)

Chinese Proprietary Medicine Xianling Gubao Capsule for Osteoporosis: A Systematic Review and Meta-Analysis of Randomized Clinical Trials
por: Cheng, Bai-Ru, et al.
Publicado: (2022)

Mapping theme trends and recognizing hot spots in postmenopausal osteoporosis research: a bibliometric analysis
por: Zhou, Siming, et al.
Publicado: (2019)

Role of the major histocompatibility complex class II protein presentation pathway in bone immunity imbalance in postmenopausal osteoporosis
por: Wang, Xiaoning, et al.
Publicado: (2022)

Efficacy and Safety of Eldecalcitol for Osteoporosis: A Meta-Analysis of Randomized Controlled Trials
por: Liu, Hongyan, et al.
Publicado: (2022)

The efficacy of alendronate for the treatment of thalassemia-associated osteoporosis: a randomized controlled trial
por: Piriyakhuntorn, Pokpong, et al.
Publicado: (2023)

Osteoporosis and sarcopenia-related traits: A bi-directional Mendelian randomization study
por: Liu, Chao, et al.
Publicado: (2022)

The relationship between the monocyte-to-lymphocyte ratio and osteoporosis in postmenopausal females with T2DM: A retrospective study in Chinese population
por: Li, Hailin, et al.
Publicado: (2023)

Vitamin K(2) Therapy for Postmenopausal Osteoporosis
por: Iwamoto, Jun
Publicado: (2014)

Low BMI, blood calcium and vitamin D, kyphosis time, and outdoor activity time are independent risk factors for osteoporosis in postmenopausal women
por: Tang, Guo, et al.
Publicado: (2023)

Mechanism and Experimental Verification of Luteolin for the Treatment of Osteoporosis Based on Network Pharmacology
por: Liang, Guihong, et al.
Publicado: (2022)

Osteoporosis-Related Randomized Clinical Trials With Middle-Aged and Older Adults Registered on the International Clinical Trials Registry Platform
por: Lai, Fenghua, et al.
Publicado: (2021)

Causal association of NAFLD with osteoporosis, fracture and falling risk: a bidirectional Mendelian randomization study
por: Cui, Aiyong, et al.
Publicado: (2023)

Acupuncture and moxibustion for primary osteoporosis: An overview of systematic review
por: Xu, Guixing, et al.
Publicado: (2020)

Systematic Influence of Circulating Bilirubin Levels on Osteoporosis
por: Zhao, Jinqiu, et al.
Publicado: (2021)

Biomarkers as therapy monitoring for postmenopausal osteoporosis: a systematic review
por: Migliorini, Filippo, et al.
Publicado: (2021)

Use of Mendelian Randomization to Examine Causal Inference in Osteoporosis
por: Zheng, Jie, et al.
Publicado: (2019)

Osteoporosis Therapy With Denosumab in Organ Transplant Recipients
por: Brunova, Jana, et al.
Publicado: (2018)

Bioinformatics identification and experimental validation of m6A-related diagnostic biomarkers in the subtype classification of blood monocytes from postmenopausal osteoporosis patients
por: Zhang, Peng, et al.
Publicado: (2023)

New Antiresorptive Therapies for Postmenopausal Osteoporosis
por: Choi, Hee-Jeong
Publicado: (2015)

Postmenopausal Osteoporosis
por: Kamel, Hosem K.
Publicado: (2006)

Effect of Exercises on Quality of Life in Patients with Postmenopausal Osteoporosis – Randomized Trial
por: Koevska, Valentina, et al.
Publicado: (2019)

Osteoporosis Therapy: Bone Modeling during Growth and Aging
por: Sugiyama, Toshihiro, et al.
Publicado: (2017)

Prospect of Stem Cell Therapy and Regenerative Medicine in Osteoporosis
por: Arjmand, Babak, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_52jfqk9255g6cfba0g1prb8uqr